Golub Capital announced that as sole lead arranger and administrative agent it provided a senior credit facility to support the acquisition of C.B. Fleet Company dba Fleet Laboratories by Gryphon Investors along with several minority investors. This marks Golub Capital’s fourth transaction with Gryphon.
“Fleet Laboratories is a unique and attractive platform in the OTC health and personal care market due to its scale, established infrastructure, and portfolio of well-established, trusted, and widely recognized brands,” said Spyro Alexopoulos, managing director at Golub Capital. “Gryphon and management have proven brand building capabilities and we are excited to partner with them to continue to grow the business.”
“This is our fourth transaction with Golub Capital in the past four years and it continues to be a strong relationship, said Dorian Faust, Managing Director at Gryphon. Golub’s reliability, flexibility and ease of execution were all differentiating factors in our choice of a credit provider to lead the senior debt financing of this transaction and they delivered. We look forward to continuing our partnership through the life of this investment as we make accretive acquisitions of attractive OTC brands.”
San Francisco-based Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management teams.
Fleet Laboratories manufactures and markets a portfolio of over-the-counter branded health and personal care products in the feminine hygiene, gastrointestinal and infant care categories.